{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:55:29Z","timestamp":1791982529590,"version":"4.4.0"},"reference-count":45,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"unspecified","delay-in-days":13,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"accepted":{"date-parts":[[2026,9,1]]},"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1136\/rmdopen-2026-007126","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:36:44Z","timestamp":1791981404000},"page":"e007126","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond disease activity: patient-reported impact of disease states in psoriatic arthritis using PsAID-12 time-independent clustering"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6240-8875","authenticated-orcid":false,"given":"De Groot","family":"P","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Erasmus MC, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tchetverikov","family":"I","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Albert Schweitzer Hospital, Dordrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bekelaar","family":"J W R","sequence":"additional","affiliation":[{"name":"Department of Quality and Safety, Maxima Medical Centre, Veldhoven, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3787-4552","authenticated-orcid":false,"given":"Koc","family":"G H","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Erasmus MC, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2319-7777","authenticated-orcid":false,"given":"Snoeck","family":"Henkemans S V J","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Erasmus MC, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vis","family":"M","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Erasmus MC, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2394-6926","authenticated-orcid":false,"given":"Kok","family":"M R","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Maasstad Hospital, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bos","family":"R","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Frisius Medical Center, Leeuwarden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijsterbosch","family":"J","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Amphia Hospital, Breda, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"van der Kaap","family":"J H","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Admiraal De Ruyter Hospital, Goes, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kok","family":"P","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Reinier de Graaf Gasthuis, Delft, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Visser","family":"K","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Haga Hospital, The Hague, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Korswagen","family":"L A","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Franciscus Gasthuis and Vlietland, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"van Oosterhout","family":"M","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Groene Hart Hospital, Gouda, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Foolen","family":"J","sequence":"additional","affiliation":[{"name":"Orthopaedic Biomechanics, Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands"},{"name":"DEPAR Patient Research Partner, Erasmus MC, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1071-7932","authenticated-orcid":false,"given":"Luime","family":"J J","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Erasmus MC, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,10,14]]},"reference":[{"key":"2026101405351432000_12.4.e007126.1","first-page":"S22","article-title":"Outcome measures in psoriatic arthritis: where next?","volume":"20 Suppl 1","author":"Hackett","year":"2022","journal-title":"Musculoskeletal Care"},{"key":"2026101405351432000_12.4.e007126.2","doi-asserted-by":"crossref","first-page":"4886","DOI":"10.1093\/rheumatology\/keaf247","article-title":"Psoriatic arthritis flare incidence, definition and risk factors: a systematic review","volume":"64","author":"Hojeij","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"2026101405351432000_12.4.e007126.3","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev009"},{"key":"2026101405351432000_12.4.e007126.4","article-title":"Implementation of the treat-to-target approach in psoriatic arthritis and its outcomes in routine clinical practice","volume":"15","author":"Din","year":"2023","journal-title":"Cureus"},{"key":"2026101405351432000_12.4.e007126.5","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2024-225531"},{"key":"2026101405351432000_12.4.e007126.6","doi-asserted-by":"crossref","first-page":"152546","DOI":"10.1016\/j.semarthrit.2024.152546","article-title":"Barriers and facilitators to application of treat-to-target management in psoriatic arthritis and axial spondyloarthritis in practice: a systematic literature review","volume":"69","author":"Webers","year":"2024","journal-title":"Semin Arthritis Rheum"},{"key":"2026101405351432000_12.4.e007126.7","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/rheumatology\/keae172","article-title":"Enhancing current guidance for psoriatic arthritis and its comorbidities: recommendations from an expert consensus panel","volume":"64","author":"Coates","year":"2025","journal-title":"Rheumatology"},{"key":"2026101405351432000_12.4.e007126.8","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-022-00443-y"},{"key":"2026101405351432000_12.4.e007126.9","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.180267"},{"key":"2026101405351432000_12.4.e007126.10","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214140"},{"key":"2026101405351432000_12.4.e007126.11","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1136\/annrheumdis-2024-eular.4743","article-title":"AB0954 When patients in remission feel not to be in remission \u2013 a qualitative study on patients with rheumatoid and psoriatic arthritis","volume":"83","author":"Lackner","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"2026101405351432000_12.4.e007126.12","doi-asserted-by":"crossref","first-page":"105372","DOI":"10.1016\/j.jbspin.2022.105372","article-title":"Residual patient-reported burden in 444 patients with psoriatic arthritis in remission or low disease: a cross-sectional analysis","volume":"89","author":"Lucasson","year":"2022","journal-title":"Joint Bone Spine"},{"key":"2026101405351432000_12.4.e007126.13","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.181077"},{"key":"2026101405351432000_12.4.e007126.14","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003548","article-title":"Validity and score interpretation of the 12-item Psoriatic Arthritis Impact of Disease: an analysis of pooled data from two phase 3 trials of bimekizumab in patients with psoriatic arthritis","volume":"10","author":"Gossec","year":"2024","journal-title":"RMD Open"},{"key":"2026101405351432000_12.4.e007126.15","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1093\/rheumatology\/kead209","article-title":"Psoriatic Arthritis Impact of Disease (PsAID) questionnaire: closer to the all-in-one tool?","volume":"62","author":"Queiro","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"2026101405351432000_12.4.e007126.16","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211996"},{"key":"2026101405351432000_12.4.e007126.17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ymeth.2025.10.010","article-title":"Explainable machine learning-based prediction of psoriatic arthritis flares using heterogenous real-world data for personalised patient care","volume":"246","author":"Moon","year":"2026","journal-title":"Methods"},{"key":"2026101405351432000_12.4.e007126.18","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.2025-0327"},{"key":"2026101405351432000_12.4.e007126.19","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1093\/rheumatology\/keaf002","article-title":"Variability of Psoriatic Arthritis Impact of Disease questionnaire (PsAID12) thresholds in psoriatic arthritis: data from the ReFlaP study","volume":"64","author":"L\u00f3pez-Medina","year":"2025","journal-title":"Rheumatology"},{"key":"2026101405351432000_12.4.e007126.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2023.115265"},{"key":"2026101405351432000_12.4.e007126.21","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.2024-0519"},{"key":"2026101405351432000_12.4.e007126.22","doi-asserted-by":"crossref","unstructured":"Everitt BS , Landau S , Leese M . Cluster analysis.5th edn. 2011.","DOI":"10.1002\/9780470977811"},{"key":"2026101405351432000_12.4.e007126.23","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-001845","article-title":"Clinically relevant patient clusters identified by machine learning from the clinical development programme of secukinumab in psoriatic arthritis","volume":"7","author":"Pournara","year":"2021","journal-title":"RMD Open"},{"key":"2026101405351432000_12.4.e007126.24","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-001728","article-title":"Identification of clinical phenotypes of peripheral involvement in patients with spondyloarthritis, including psoriatic arthritis: a cluster analysis in the worldwide ASAS-PerSpA study","volume":"7","author":"L\u00f3pez-Medina","year":"2021","journal-title":"RMD Open"},{"key":"2026101405351432000_12.4.e007126.25","doi-asserted-by":"crossref","DOI":"10.1093\/rap\/rkaf031","article-title":"Disease burden in inflammatory arthritis: an unsupervised machine learning approach of the COVAD-2 e-survey dataset","volume":"9","author":"Venerito","year":"2025","journal-title":"Rheumatol Adv Pract"},{"key":"2026101405351432000_12.4.e007126.26","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/ard-2024-226150","article-title":"Psoriatic arthritis phenotype clusters and their association with treatment response: a real-world longitudinal cohort study from the psoriatic arthritis research consortium","volume":"84","author":"Karmacharya","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"2026101405351432000_12.4.e007126.27","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1007\/s10067-026-07994-3","article-title":"Exploring clinical subtypes of Chinese patients with psoriatic arthritis based on cluster analysis: a national registry study (CREPAR V)","volume":"45","author":"Zhao","year":"2026","journal-title":"Clin Rheumatol"},{"key":"2026101405351432000_12.4.e007126.28","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/03009742.2020.1803398","article-title":"Lessons learned from clinical phenotypes in early psoriatic arthritis: the real-world Dutch south west Early Psoriatic ARthritis study","volume":"50","author":"Kasiem","year":"2021","journal-title":"Scand J Rheumatol"},{"key":"2026101405351432000_12.4.e007126.29","doi-asserted-by":"publisher","DOI":"10.1002\/art.21972"},{"key":"2026101405351432000_12.4.e007126.30","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205207"},{"key":"2026101405351432000_12.4.e007126.31","doi-asserted-by":"crossref","first-page":"105181","DOI":"10.1016\/j.jmva.2023.105181","article-title":"Selecting the number of clusters, clustering models, and algorithms: a unifying approach based on the quadratic discriminant score","volume":"196","author":"Coraggio","year":"2023","journal-title":"J Multivar Anal"},{"key":"2026101405351432000_12.4.e007126.32","doi-asserted-by":"publisher","DOI":"10.1373\/49.8.1258"},{"key":"2026101405351432000_12.4.e007126.33","doi-asserted-by":"crossref","first-page":"101669","DOI":"10.1016\/j.berh.2021.101669","article-title":"Diagnosis, classification, and assessment in psoriatic arthritis","volume":"35","author":"Antony","year":"2021","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2026101405351432000_12.4.e007126.34","first-page":"696","article-title":"Patient clusters identified by machine learning from a pooled analysis of the clinical development programme of secukinumab in psoriatic arthritis, ankylosing spondylitis and psoriatic arthritis with axial manifestations","volume":"42","author":"Baraliakos","year":"2024","journal-title":"Clin Exp Rheumatol"},{"key":"2026101405351432000_12.4.e007126.35","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.ard.2025.04.011","article-title":"Time-independent disease state identification defines distinct trajectories determined by localised vs systemic inflammation in patients with early rheumatoid arthritis","volume":"84","author":"Steinz","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"2026101405351432000_12.4.e007126.36","doi-asserted-by":"crossref","DOI":"10.1007\/s00296-025-05791-w","article-title":"Severity of skin disease strongly correlates with quality of life in people with psoriatic arthritis: a systematic review","volume":"45","author":"Pitzalis","year":"2025","journal-title":"Rheumatol Int"},{"key":"2026101405351432000_12.4.e007126.37","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-215003"},{"key":"2026101405351432000_12.4.e007126.38","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s40744-020-00221-8","article-title":"Disease characteristics and the burden of joint and skin involvement amongst people with psoriatic arthritis: a population survey","volume":"7","author":"Tillett","year":"2020","journal-title":"Rheumatol Ther"},{"key":"2026101405351432000_12.4.e007126.39","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab606"},{"key":"2026101405351432000_12.4.e007126.40","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/acr.23330","article-title":"Impact of disease severity, illness beliefs, and coping strategies on outcomes in psoriatic arthritis","volume":"70","author":"Howells","year":"2018","journal-title":"Arthritis Care Res"},{"key":"2026101405351432000_12.4.e007126.41","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s11136-016-1369-4","article-title":"Focus group interviews reveal reasons for differences in the perception of disease activity in rheumatoid arthritis","volume":"26","author":"Walter","year":"2017","journal-title":"Qual Life Res"},{"key":"2026101405351432000_12.4.e007126.42","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003339","article-title":"Triple jump for the optimal management of psoriatic arthritis: diet, sleep and exercise - a review","volume":"9","author":"Lubrano","year":"2023","journal-title":"RMD Open"},{"key":"2026101405351432000_12.4.e007126.43","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s40744-025-00759-5","article-title":"Psychological health in the management of patients with psoriatic arthritis: an intricate relationship","volume":"12","author":"Lubrano","year":"2025","journal-title":"Rheumatol Ther"},{"key":"2026101405351432000_12.4.e007126.44","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/rheumatology\/kead679","article-title":"How do patient-reported outcome measures affect treatment intensification and patient satisfaction in the management of psoriatic arthritis? A cross sectional study of 503 patients","volume":"64","author":"Coyle","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"2026101405351432000_12.4.e007126.45","doi-asserted-by":"crossref","first-page":"e220","DOI":"10.1016\/S2665-9913(21)00349-0","article-title":"The state of the art-psoriatic arthritis outcome assessment in clinical trials and daily practice","volume":"4","author":"Day","year":"2022","journal-title":"Lancet Rheumatol"}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2026-007126","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:36:49Z","timestamp":1791981409000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2026-007126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":45,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,10,14]]},"published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1136\/rmdopen-2026-007126"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2026-007126","relation":{},"ISSN":["2056-5933"],"issn-type":[{"value":"2056-5933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]}}}